Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Generalized Anxiety Disorder Global Market Report 2025
Download Free Sample Buy Now
Global Generalized Anxiety Disorder Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Generalized Anxiety Disorder Global Market Report 2025

By Type (Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types), By Therapies (Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy), By Device (Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Generalized Anxiety Disorder Market Overview

• Generalized Anxiety Disorder market size has reached to $7.76 billion in 2024

• Expected to grow to $9.2 billion in 2029 at a compound annual growth rate (CAGR) of 3.8%

• Growth Driver: Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market

• Market Trend: Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment

• North America was the largest region in 2024.

What Is Covered Under Generalized Anxiety Disorder Market?

Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry, fear and anxiety about various aspects of life. It involves a broad range of concerns that can often feel uncontrollable and overwhelming. The treatment decisions change based on how significantly GAD is affecting a person's ability to function in daily life.

The main types of generalized anxiety disorder are panic disorder, agoraphobia, generalized anxiety, social anxiety, specific phobia and others. Panic disorder refers to a mental health condition characterized by recurring and unexpected episodes of intense fear and discomfort known as panic attacks. It can be treated by various therapies, such as interpersonal therapy, behavior therapy, cognitive behavioral therapy and mindfulness-based cognitive therapy, by using different types of devices, including deep brain stimulation, electroconvulsive therapy, transcranial magnetic stimulation and vagus nerve stimulation. These are utilized by hospitals, homecare, specialty clinics and others.

Generalized Anxiety Disorder Market Size and growth rate 2025 to 2029: Graph

What Is The Generalized Anxiety Disorder Market Size 2025 And Growth Rate?

The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.76 billion in 2024 to $7.93 billion in 2025 at a compound annual growth rate (CAGR) of 2.2%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes.

What Is The Generalized Anxiety Disorder Market Growth Forecast?

The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $9.2 billion in 2029 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to digital mental health solutions, genetic research, integrated care models, global mental health awareness. Major trends in the forecast period include holistic approaches, cultural competence, early intervention, artificial intelligence (AI) in diagnosis.

The forecast of 3.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. mental health by restricting access to SSRIs and benzodiazepines imported from India and Israel, potentially compromising treatment adherence and increasing psychiatric care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Generalized Anxiety Disorder Market Segmented?

1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types

2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy

3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks

2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety

3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety

4) By Social Anxiety: Performance Anxiety, Interaction Anxiety

5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia

6) Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)

What Is Driving The Generalized Anxiety Disorder Market? Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market

The rising number of mental disorder cases in the healthcare industry is driving the growth of the generalized anxiety disorder market. A mental disorder, also known as a mental illness, refers to a wide range of conditions that affect a person's thoughts, emotions, behaviors and overall mental well-being. Mental health disorders that commonly occur with generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD) and managing these conditions is crucial for individuals to maintain healthy relationships and improve their quality of life. For instance, in November 2023, according to Stress in America 2023 survey published by American Psychological Association, a US-based professional organization, adults aged 35 to 44 experienced the highest increase in mental health diagnoses, 45% reported a mental illness in 2023 compared with 31%. However, adults ages 18 to 34 still reported the highest rate of mental illnesses at 50% in 2023. Therefore, the rising number of mental disorder cases is expected to propel the growth of the generalized anxiety disorder industry.

What Is Driving The Generalized Anxiety Disorder Market? Government Initiatives Fueling Growth In The Generalized Anxiety Disorder (GAD) Market

Growing government initiatives are driving the growth of the generalized anxiety disorder market. A government initiative is a plan or action taken by a government to address a specific problem or issue that can be funded by various sources, including taxes, grants, and donations. Government initiatives are used to address generalized anxiety disorder (GAD) by funding research that can help to understand the causes and treatment of GAD better and to develop new and more effective ways to help people with this condition. For instance, in March 2022, the Department of Health and Human Services (HHS), a US-based provider of essential human services, announced funding possibilities totaling almost $35 million to improve and grow community mental health services and suicide prevention initiatives for children and young people in America. Therefore, the growing government initiatives are expected to propel the growth of the generalized anxiety disorder industry.

Who Are The Major Players In The Global Generalized Anxiety Disorder Market?

Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.

What Are The Key Trends Of The Global Generalized Anxiety Disorder Market? Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment

Major companies operating in the generalized anxiety disorder market are developing innovative drugs such as MM-120 and getting approval for the treatment of generalized anxiety disorder to better meet the needs of their existing consumers. Innovative drugs such as MM-120 aim to improve the management and outcomes of this mental health condition. For instance, in January 2022, Mind Medicine Inc., a US-based psychedelic medicine biotech company, received approval for an Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA), allowing the company’s phase IIb dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder (GAD) to proceed. MM-120 is a small molecule that acts as a partial agonist of the 5-HT2A receptor. This receptor is involved in the regulation of mood, anxiety and perception. Moreover, MM-120 is thought to work by increasing serotonin levels in the brain and this could pave the way for other psychedelic compounds to be developed to treat mental health disorders.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Generalized Anxiety Disorder Market? Big Health's Strategic Acquisition Enhances Digital Therapeutics For Mental Health

In July 2023, Big Health, a US-based digital therapeutics company, acquired Limbix Health Inc. for an undisclosed amount. With this acquisition, Big Health aims to make a strategic move that will allow the two companies to combine their expertise and resources to develop and deliver more effective digital therapeutics for mental health conditions. Limbix Health Inc. is a US-based digital therapeutics platform that provides mental health treatment for young people suffering from depression, anxiety and other mental illnesses.

Regional Outlook For The Global Generalized Anxiety Disorder Market

North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generalized Anxiety Disorder Market?

The generalized anxiety disorder market consists of revenues earned by entities by providing services such as exposure therapy, supportive psychotherapy, relaxation therapies, group therapy, stress management and self-care practices. The market value includes the value of related goods sold by the service provider or included within the service offering. The generalized anxiety disorder market also includes sales of pregabalin, hydroxyzine, beta-blockers, atypical antipsychotics and alprazolam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Generalized Anxiety Disorder Industry?

The generalized anxiety disorder market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generalized anxiety disorder industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Generalized Anxiety Disorder Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $7.93 billion
Revenue Forecast In 2034 $9.2 billion
Growth Rate CAGR of 3.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types
2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users Subsegments: 1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety
4) By Social Anxiety: Performance Anxiety, Interaction Anxiety
5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia 6) Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Alkermes plc, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals plc, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Generalized Anxiety Disorder Market Characteristics

3. Generalized Anxiety Disorder Market Trends And Strategies

4. Generalized Anxiety Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Generalized Anxiety Disorder Growth Analysis And Strategic Analysis Framework

5.1. Global Generalized Anxiety Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Generalized Anxiety Disorder Market Growth Rate Analysis

5.4. Global Generalized Anxiety Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Generalized Anxiety Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Generalized Anxiety Disorder Total Addressable Market (TAM)

6. Generalized Anxiety Disorder Market Segmentation

6.1. Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Panic Disorder

Agoraphobia

Generalized Anxiety

Social Anxiety

Specific Phobia

Other Types

6.2. Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interpersonal Therapy

Behavior Therapy

Cognitive Behavioral Therapy

Mindfulness Based Cognitive Therapy

6.3. Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deep Brain Stimulation

Electroconvulsive Therapy

Transcranial Magnetic Stimulation

Vagus Nerve Stimulation

6.4. Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.5. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recurrent Panic Attacks

Unexpected Panic Attacks

6.6. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Situational Phobia

Open Spaces Anxiety

6.7. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Generalized Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Worry

Excessive Anxiety

6.8. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Social Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Performance Anxiety

Interaction Anxiety

6.9. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Specific Phobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Animal Phobia

Environmental Phobia

Situational Phobia

6.10. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Separation Anxiety Disorder

Selective Mutism

Post-Traumatic Stress Disorder (PTSD)

7. Generalized Anxiety Disorder Market Regional And Country Analysis

7.1. Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generalized Anxiety Disorder Market

8.1. Asia-Pacific Generalized Anxiety Disorder Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generalized Anxiety Disorder Market

9.1. China Generalized Anxiety Disorder Market Overview

9.2. China Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generalized Anxiety Disorder Market

10.1. India Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generalized Anxiety Disorder Market

11.1. Japan Generalized Anxiety Disorder Market Overview

11.2. Japan Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generalized Anxiety Disorder Market

12.1. Australia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generalized Anxiety Disorder Market

13.1. Indonesia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generalized Anxiety Disorder Market

14.1. South Korea Generalized Anxiety Disorder Market Overview

14.2. South Korea Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generalized Anxiety Disorder Market

15.1. Western Europe Generalized Anxiety Disorder Market Overview

15.2. Western Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generalized Anxiety Disorder Market

16.1. UK Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generalized Anxiety Disorder Market

17.1. Germany Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generalized Anxiety Disorder Market

18.1. France Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generalized Anxiety Disorder Market

19.1. Italy Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generalized Anxiety Disorder Market

20.1. Spain Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generalized Anxiety Disorder Market

21.1. Eastern Europe Generalized Anxiety Disorder Market Overview

21.2. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generalized Anxiety Disorder Market

22.1. Russia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generalized Anxiety Disorder Market

23.1. North America Generalized Anxiety Disorder Market Overview

23.2. North America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generalized Anxiety Disorder Market

24.1. USA Generalized Anxiety Disorder Market Overview

24.2. USA Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generalized Anxiety Disorder Market

25.1. Canada Generalized Anxiety Disorder Market Overview

25.2. Canada Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generalized Anxiety Disorder Market

26.1. South America Generalized Anxiety Disorder Market Overview

26.2. South America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generalized Anxiety Disorder Market

27.1. Brazil Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generalized Anxiety Disorder Market

28.1. Middle East Generalized Anxiety Disorder Market Overview

28.2. Middle East Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generalized Anxiety Disorder Market

29.1. Africa Generalized Anxiety Disorder Market Overview

29.2. Africa Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generalized Anxiety Disorder Market Competitive Landscape And Company Profiles

30.1. Generalized Anxiety Disorder Market Competitive Landscape

30.2. Generalized Anxiety Disorder Market Company Profiles

30.2.1. Alkermes plc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Generalized Anxiety Disorder Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc

31.2. AstraZeneca plc

31.3. Abbott Laboratories

31.4. 3M Company

31.5. Boehringer Ingelheim International GmbH

31.6. Johnson And Johnson Private Limited

31.7. Adobe Inc.

31.8. Baxter International Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Otsuka Holdings Co. Ltd.

31.11. Mylan N.V.

31.12. Sumitomo Pharma Co. Ltd.

31.13. Jazz Pharmaceuticals plc

31.14. Forest Laboratories Inc.

31.15. H. Lundbeck A/S

32. Global Generalized Anxiety Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generalized Anxiety Disorder Market

34. Recent Developments In The Generalized Anxiety Disorder Market

35. Generalized Anxiety Disorder Market High Potential Countries, Segments and Strategies

35.1 Generalized Anxiety Disorder Market In 2029 - Countries Offering Most New Opportunities

35.2 Generalized Anxiety Disorder Market In 2029 - Segments Offering Most New Opportunities

35.3 Generalized Anxiety Disorder Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Generalized Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Social Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Specific Phobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Alkermes plc Financial Performance
  • Table 82: Pfizer Inc. Financial Performance
  • Table 83: F. Hoffmann-La Roche AG Financial Performance
  • Table 84: Sanofi SA Financial Performance
  • Table 85: Bristol-Myers Squibb Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Generalized Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Social Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Specific Phobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Alkermes plc Financial Performance
  • Figure 82: Pfizer Inc. Financial Performance
  • Figure 83: F. Hoffmann-La Roche AG Financial Performance
  • Figure 84: Sanofi SA Financial Performance
  • Figure 85: Bristol-Myers Squibb Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Read More About Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Read More About Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Read More About Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

Read More About Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Generalized Anxiety Disorder Global Market Report 2025 – By Type (Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types), By Therapies (Interpersonal Therapy, Behavior Therapy, Co...

View Report

Panic Disorders Global Market Report 2025 – By Type (Agoraphobia, Social Anxiety Disorder  (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder), ...

View Report

Major Depressive Disorder Global Market Report 2025 – By Treatment (Psychotherapy, Medications, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Other Treatments), By Diagnosis (Physical Examinat...

View Report

Behavioral Therapy Global Market Report 2025 – By Type (Cognitive Behavioral Therapy, Systematic Desensitization, Aversion Therapy, Cognitive Behavioral Play Therapy, Other Types), By Treatment Settings (Hospitals, Commu...

View Report

Cognitive Behavioral Therapy Global Market Report 2025 – By Type (Cognitive Behavioral Therapy, Cognitive Behavioral Play Therapy, Desensitization, Aversion Therapy, Other Types), By Age Group (Children, Adult, Geriatric...

View Report

Mental Health Global Market Report 2025 – By Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Eating Disorders, Other Disor...

View Report

Post-Traumatic Stress Disorder Therapeutics Global Market Report 2025 – By Drug Class (Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs),...

View Report

Mental Health Apps Global Market Report 2025 – By Platform Type (iOS, Android, Other Platform Types), By Application Type (Depression and Anxiety management, Meditation Management, Stress Management, Wellness Management,...

View Report

Frequently Asked Questions

Generalized anxiety disorder (GAD) is a mental health condition characterized by excessive and persistent worry, fear and anxiety about various aspects of life. It involves a broad range of concerns that can often feel uncontrollable and overwhelming. The treatment decisions change based on how significantly GAD is affecting a person's ability to function in daily life. For further insights on this market, request a sample here

The market major growth driver - Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder Market. For further insights on this market, request a sample here

The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.76 billion in 2024 to $7.93 billion in 2025 at a compound annual growth rate (CAGR) of 2.2%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes. The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to " $9.2 billion in 2029 at a compound annual growth rate (CAGR) of 3.8%. The growth in the forecast period can be attributed to digital mental health solutions, genetic research, integrated care models, global mental health awareness. Major trends in the forecast period include holistic approaches, cultural competence, early intervention, artificial intelligence (AI) in diagnosis. For further insights on this market, request a sample here

The generalized anxiety disordermarket covered in this report is segmented –
1) By Type: Panic Disorder; Agoraphobia; Generalized Anxiety; Social Anxiety; Specific Phobia; Other Types
2) By Therapies: Interpersonal Therapy; Behavior Therapy; Cognitive Behavioral Therapy; Mindfulness Based Cognitive Therapy
3) By Device: Deep Brain Stimulation; Electroconvulsive Therapy; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation
4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users Subsegments:
1) By Panic Disorder: Recurrent Panic Attacks; Unexpected Panic Attacks
2) By Agoraphobia: Situational Phobia; Open Spaces Anxiety
3) By Generalized Anxiety: Chronic Worry; Excessive Anxiety
4) By Social Anxiety: Performance Anxiety; Interaction Anxiety
5) By Specific Phobia: Animal Phobia; Environmental Phobia; Situational Phobia
6) Other Type: Separation Anxiety Disorder; Selective Mutism; Post-Traumatic Stress Disorder (PTSD) For further insights on this market, request a sample here

North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in generalized anxiety disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Drug Development Revolutionizes Generalized Anxiety Disorder Treatment. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Generalized Anxiety Disorder Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon